We are live on ! Find out more
BPTH

Bio-Path Holdings Inc
BPTH

Delisted

BPTH was delisted on the 18th of February, 2025.

Back to rankings

14 hedge funds and large institutions have $53.5K invested in Bio-Path Holdings Inc in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

8% more funds holding

Funds holding: 13 → 14 (+1)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

81% less capital invested

Capital invested by funds: $285K → $53.5K (-$232K)

Holders
14
Holders Change
+1
Holders Change %
+7.69%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$17K
2
Citadel Advisors
Citadel Advisors
Florida
+$15K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$3.76K
4
UBS Group
UBS Group
Switzerland
+$2.75K
5
EWA
EverSource Wealth Advisors
Alabama
+$14

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$194K
2
HF
HRT Financial
New York
-$28K
3
TRCT
Tower Research Capital (TRC)
New York
-$498
4
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$200
5
Bank of America
Bank of America
North Carolina
-$26
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
1
Geode Capital Management
Massachusetts
$12.4K +$3.76K +2,732 +25%
Vanguard Group
2
Vanguard Group
Pennsylvania
$12.3K – – –
VF
3
Virtu Financial
New York
$11K +$17K +12,325 New
Citadel Advisors
4
Citadel Advisors
Florida
$9.93K +$15K +10,917 New
TRCT
5
Tower Research Capital (TRC)
New York
$3.07K -$498 -362 -10%
UBS Group
6
UBS Group
Switzerland
$2.6K +$2.75K +1,997 +232%
BlackRock
7
BlackRock
New York
$2.17K – – –
Morgan Stanley
8
Morgan Stanley
New York
$32 – – –
Bank of America
9
Bank of America
North Carolina
$24 -$26 -19 -41%
Group One Trading
10
Group One Trading
Illinois
$19 – – –
EWA
11
EverSource Wealth Advisors
Alabama
$9 +$14 +10 New
GRP
12
Global Retirement Partners
California
$4 – – –
DB
13
Danske Bank
Denmark
$2 +$3 +2 New
AF
14
Allworth Financial
California
$1 – – –
AC
15
Armistice Capital
New York
– -$194K -97,000 Closed
HF
16
HRT Financial
New York
– -$28K -14,085 Closed
Qube Research & Technologies (QRT)
17
Qube Research & Technologies (QRT)
United Kingdom
– -$200 -100 Closed

BPTH Hedge Fund Activity: Q3 2024 in Review

14 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings Inc (BPTH) for Q3 2024, worth a combined $53.5K — down 81% from $285K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new BPTH positions and 3 closed out — a net gain of 1 holder — while 2 added to existing stakes and 2 trimmed.

The largest buyer was Virtu Financial, opening a new position worth an estimated $17K. The largest seller was Armistice Capital, exiting entirely with an estimated $194K sold.

  • 14 institutional investors held Bio-Path Holdings Inc (BPTH) as of Q3 2024, up from 13 in Q2 2024.
  • Funds reported $53.5K of Bio-Path Holdings Inc stock for Q3 2024, down 81% quarter-over-quarter.
  • 4 funds opened new Bio-Path Holdings Inc positions in Q3 2024 and 3 closed out, a net change of +1 holder.
  • The largest Bio-Path Holdings Inc buyer in Q3 2024 was Virtu Financial, an estimated $17K added.
  • The largest Bio-Path Holdings Inc seller in Q3 2024 was Armistice Capital, an estimated $194K sold.

Based on aggregated 13F filings for Q3 2024.